Stock·NASDAQ·Technology
DocuSign Inc. (DOCU)
- Market cap
- $14.49B
- P/E
- 44.09
- Dividend yield
- 0.00%
- Street target
- $72.00median of 20 analysts
- 52-week range
- $40.16 $77.60
The short version
Where DOCU stands today, in four lines, and what CleaRank Financial AI makes of it.
DOCU at a glance
DocuSign Inc. (DOCU): Hold, 55/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($66.14 and $53.77).
- Earnings DOCU beat estimates in 8 of its last 8 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $37.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 44.1 against 35.1 for the Technology sector: a premium to peers (+26%).
Figures as of October 16, 2026.
CleaRank Financial AI
DocuSign Inc. (DOCU) is currently trading at $77.52, above its 50-day and 200-day moving averages ($66.14 and $53.77), indicating positive short-to-medium term price momentum.
The stock's 14-day RSI is 72.42, signaling an overbought condition that may precede a pullback. Despite the technical strength, the median Wall Street price target of $72.00 suggests limited upside from current levels, and a moderate sell signal from insider transactions further tempers the bullish outlook. Fundamental analysis shows DocuSign trading at a Price-to-Sales ratio of 4.02, which is below the sector median of 7.6, suggesting a potential valuation discount relative to peers. The company maintains a healthy profit margin of 9.82% and a strong return on equity of 17.80%. However, the consensus rating is 'Hold', reflecting a balance between positive technicals and cautious analyst sentiment, with a significant portion of analysts maintaining a 'Hold' rating.
Only on CleaRank
Figures we compute ourselves from DOCU's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $77.52 is 17.2% above the 50-day simple moving average of $66.14.Price above its 200-day average ›
The price is 44.2% above the 200-day simple moving average of $53.77.50-day average above the 200-day ›
The 50-day average ($66.14) is 23.0% above the 200-day average ($53.77), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 100% of its 52-week range, between $40.16 and $77.60.
DOCU share price
Pick a period: each tab shows how far DOCU has moved over it, to the last close.
Today's trading
Where DOCU sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/4P/E below the sector median ›
The trailing P/E of 44.09 is 25.6% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 4.02 is 47.1% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $329.9M on revenue of $3.4B, a net margin of 9.8%.Beat estimates in most recent reports ›
DOCU beat the EPS estimate in 8 of its last 8 reports.
Key statistics
The headline figures for DOCU.
As of October 16, 2026, DOCU trades at $77.52, with a market value of $14.49B and a P/E ratio of 44.09.
What the numbers say
CleaRank Financial AI's reading of DOCU's valuation, growth and risks.
DocuSign Inc. (DOCU) presents a mixed fundamental picture, with a Price-to-Sales ratio of 4.02 that is below the sector median of 7.6, indicating it may be undervalued compared to its peers in the software application space.
The company demonstrates solid profitability with a net profit margin of 9.82% and an operating margin of 13.43%. Its return on equity stands at a healthy 17.80%, surpassing the sector median of 13.4%. Revenue growth of 9.4% is below the sector median of 24.2%, suggesting a slower expansion rate compared to industry leaders. Despite these positive fundamental aspects, the current consensus rating is 'Hold', suggesting that the market is weighing the solid fundamentals against other factors, such as growth expectations or valuation concerns.
DOCU against the Technology sector
How DOCU compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: DOCU trades at a significant premium to sector peers (+26%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 5, 2025, DOCU has lost 6.0% against a gain of 75.6% for XLK.
Performance against XLK
DOCU and the Technology sector fund over the same days.
Revenue and earnings
How much DOCU sells, and how much of it becomes profit.
Revenue growth: Revenue grew 8.2% in FY2026 to $3.2B, from $3.0B a year earlier.
Profit margin: The net margin was 9.6% in FY2026, down from 35.9% the year before.
Profitable: DOCU earned $309M in FY2026.
Earnings reality check
Did DOCU beat what analysts expected, and how did the stock react?
Earnings record: DOCU beat the analyst estimate in 8 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 8 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Sep 3, 2026after close | $1.09 | $1.16 | +6.42% | +3.70% | -0.49% |
| Jun 4, 2026after close | $0.99 | $1.09 | +10.10% | -7.22% | -12.54% |
| Dec 4, 2025after close | $0.92 | $1.01 | +9.78% | -7.64% | -1.22% |
| Sep 4, 2025after close | $0.85 | $0.92 | +8.24% | +4.75% | +5.25% |
| Jun 5, 2025after close | $0.81 | $0.90 | +11.11% | -18.97% | -18.18% |
| Mar 13, 2025after close | $0.85 | $0.86 | +1.18% | +14.81% | +13.94% |
| Dec 5, 2024after close | $0.87 | $0.90 | +3.45% | +27.86% | +12.95% |
| Sep 5, 2024after close | $0.81 | $0.97 | +19.75% | +3.97% | -0.77% |
As of October 16, 2026, DOCU has beaten the analyst EPS estimate in 8 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on September 3, 2026, came in 6.42% above the estimate and the stock moved +3.70% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 72.4, in overbought territory.RSI above 50 ›
An RSI of 72.4 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of DOCU
The score, the reasoning behind it, and what could move the price next.
DocuSign Inc. (DOCU) exhibits strong upward momentum, trading above its 50-day SMA of $66.14 and 200-day SMA of $53.77, with its 20-day EMA at $70.37 also below the current price.
The 14-day Relative Strength Index (RSI) stands at 72.42, indicating the stock is in overbought territory and may be due for a correction. The MACD value of 2.37 suggests positive momentum, though the overbought RSI warrants caution. Key support levels are seen around the 50-day SMA ($66.14) and the 20-day EMA ($70.37), while the current price of $77.52 acts as immediate resistance. Trading volume was significantly above average at 4.88 million shares, representing a 75.3% increase compared to the average volume, suggesting strong investor interest at current levels. The combination of overbought technicals and elevated volume indicates a potential for a short-term reversal or consolidation.
Consistent Earnings Beats ›
DocuSign Inc. (DOCU) has a track record of beating earnings estimates, most recently by 6.42% in September 2026, though stock price reactions have been mixed.
Source: Earnings Reports
Overbought Technical Conditions ›
The 14-day RSI for DocuSign Inc. (DOCU) is at 72.42, indicating the stock is overbought and may be due for a price correction.
Source: Technical Analysis
- Monitor the 14-day RSI for DocuSign Inc. (DOCU) to potentially identify a more favorable entry point if it moves back into neutral territory from its current overbought level.
Technical indicators
Momentum and trend for DOCU, from its daily closes.
As of October 16, 2026, with DOCU at $77.52, its 14-day RSI is 72.4 (overbought territory), its 50-day simple moving average is $66.14 and its 200-day is $53.77.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What DOCU moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, DOCU's 1-year correlation of daily returns is +0.34 with S&P 500 (SPY), +0.30 with Nasdaq 100 (QQQ), +0.15 with Bitcoin (BTC) and -0.04 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
0/3Most analysts rate it a buy ›
4 of 20 analysts rate it a buy or strong buy, 15 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $72.00 is 7.1% below the price.More buy ratings than three months ago ›
4 of 20 rate it a buy now, against 5 of 22 three months ago.
DOCU Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 4, 2026 | Piper Sandler | Maintains | Neutral |
| Sep 4, 2026 | Citigroup | Maintains | Neutral |
| Sep 4, 2026 | Morgan Stanley | Maintains | Equal-Weight |
| Sep 4, 2026 | B of A Securities | Maintains | Underperform |
| Sep 4, 2026 | Baird | Maintains | Neutral |
| Sep 4, 2026 | Wells Fargo | Maintains | Equal-Weight |
As of October 16, 2026, 20 Wall Street analysts cover DOCU: 4 rate it a buy or strong buy, 15 a hold and 1 a sell or strong sell. Their 12-month price targets range from $46.89 to $86.00, with a median of $72.00, 7.1% below the price of $77.52.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
DOCU trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from DOCU's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much DOCU tends to move, against the market and on its own.
The long record
DOCU's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 2.55% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 87.6%, from September 2021 to October 2023; the price is still 75.0% below that peak.Most 1-year holds ended higher ›
54% of 1-year holding periods in the last 8 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in April 2018 is now worth $19,512, against $32,914 in the S&P 500 (SPY).
DOCU Drawdowns & Recovery
As of October 16, 2026, DOCU's worst peak-to-trough fall over the last 8 years with dividends reinvested was -87.6% (September 2021 to October 2023); it is still 75.0% below that peak, and 54% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into DOCU in April 2018 is worth now, against the same amount in the S&P 500.
Against the market: DOCU trailed the S&P 500 over this period: $19,512 against $32,914.
A $10,000 investment in DOCU in April 2018 would be worth about $19,512 today with dividends reinvested, compared with about $32,914 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to DOCU, and which have not.
Strongest month, July: an average of +7.78%, up in 8 of 9 years.
Weakest month, February: an average of -2.93%, up in 4 of 8 years.
This month, October: has averaged -2.77%, up in 4 of 8 years. Past seasonality does not repeat on schedule.
Over the last 9 years, DOCU's strongest calendar month has been July (average +7.78%, up in 8 of 9 years) and its weakest February (average -2.93%, up in 4 of 8 years).
Average return for each calendar month over the last 9 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in DOCU, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in DOCU today could grow to about $19,829 by 2036 in the base case, with a 90th-percentile outcome near $150,433 and a 10th-percentile outcome around $2,614. Projections are statistical simulations, not guarantees.
DOCU Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $102 for DOCU by 2030 in the base case, from $77.52 today (1.3x over 4 years). The 10th-percentile path ends near $28.30. These are outcomes of a Monte Carlo simulation run on DOCU's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $43.74 | $83.01 | $158 | |
| 2028 | $35.92 | $88.89 | $220 | |
| 2029 | $31.37 | $95.19 | $289 | |
| 2030 | $28.30 | $102 | $367 | |
| 2031 | $26.05 | $109 | $457 |
Method: a lognormal simulation of DOCU's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
DOCU insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought DOCU shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 16, 2026, DOCU insiders reported 55 open-market sales worth $37.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Robert Chatwani
Officer
|
Sell | 14.7K | $1.0M |
| Sep 16, 2026 | Mary Agnes Wilderotter
Director
|
Sell | 1.1K | $77.4K |
| Sep 15, 2026 | Robert Chatwani
Officer
|
Grant | 35.3K | - |
| Sep 15, 2026 | Blake Jeffrey Grayson
Chief Financial Officer
|
Grant | 44.2K | - |
| Sep 15, 2026 | Paula Hansen
Officer
|
Grant | 39.4K | - |
| Sep 15, 2026 | James P Shaughnessy
Officer
|
Grant | 18.3K | - |
| Sep 15, 2026 | Allan C Thygesen
Chief Executive Officer
|
Grant | 67.5K | - |
| Sep 14, 2026 | Anna Marrs
Director
|
Sell | 548 | $36.7K |
| Sep 10, 2026 | Peter Solvik
Director
|
Sell | 46.0K | $3.0M |
| Sep 10, 2026 | Teresa Briggs
Director
|
Sell | 548 | $35.4K |
| Sep 8, 2026 | Blake Jeffrey Grayson
Chief Financial Officer
|
Sell | 45.0K | $3.1M |
| Sep 8, 2026 | Blake Jeffrey Grayson
Chief Financial Officer
|
Sell | 45.0K | $3.1M |
| Sep 4, 2026 | Brian Keith Roberts
Director
|
Grant | 856 | - |
| Sep 3, 2026 | Michael George Rosenbaum
Director
|
Grant | 522 | - |
| Sep 1, 2026 | James Alexander Beer
Director
|
Grant | 1.1K | - |
| Sep 1, 2026 | Teresa Briggs
Director
|
Grant | 1.1K | - |
| Sep 1, 2026 | Cain A. Hayes
Director
|
Grant | 1.1K | - |
| Sep 1, 2026 | Blake J Irving
Director
|
Grant | 1.1K | - |
| Sep 1, 2026 | Anna Marrs
Director
|
Grant | 1.1K | - |
| Sep 1, 2026 | Enrique T Salem
Director
|
Grant | 1.1K | - |
| Sep 1, 2026 | Peter Solvik
Director
|
Grant | 1.1K | - |
| Sep 1, 2026 | Mary Agnes Wilderotter
Director
|
Grant | 1.1K | - |
| Aug 28, 2026 | James Alexander Beer
Director
|
Sell | 450 | $28.8K |
| Jul 31, 2026 | Rowan Mehail Trollope
Director
|
Grant | 869 | - |
| Jul 1, 2026 | Allan C Thygesen
Chief Executive Officer
|
Sell | 26.3K | $1.2M |
| Jul 1, 2026 | Blake Jeffrey Grayson
Chief Financial Officer
|
Sell | 15.0K | $683.2K |
| Jul 1, 2026 | James P Shaughnessy
Officer
|
Sell | 12.0K | $546.5K |
| Jul 1, 2026 | Paula Hansen
Officer
|
Sell | 6.0K | $273.2K |
| Jun 22, 2026 | Robert Chatwani
President
|
Sell | 15.9K | $683.9K |
| Jun 15, 2026 | Robert Chatwani
Officer
|
Grant | 31.5K | - |
| Jun 15, 2026 | Blake Jeffrey Grayson
Chief Financial Officer
|
Grant | 37.5K | - |
| Jun 15, 2026 | Paula Hansen
Officer
|
Grant | 32.5K | - |
| Jun 15, 2026 | James P Shaughnessy
Officer
|
Grant | 21.0K | - |
| Jun 15, 2026 | Allan C Thygesen
Chief Executive Officer
|
Grant | 65.6K | - |
| Jun 5, 2026 | Anna Marrs
Director
|
Sell | 363 | $17.9K |
| Jun 5, 2026 | Brian Keith Roberts
Director
|
Grant | 855 | - |
| Jun 4, 2026 | Anna Marrs
Director
|
Grant | 725 | - |
| Jun 3, 2026 | Michael George Rosenbaum
Director
|
Grant | 522 | - |
| Jun 2, 2026 | James Alexander Beer
Director
|
Sell | 450 | $24.8K |
| Jun 2, 2026 | Anna Marrs
Director
|
Sell | 365 | $20.1K |
| May 29, 2026 | Teresa Briggs
Director
|
Sell | 365 | $18.3K |
| May 29, 2026 | James Alexander Beer
Director
|
Grant | 729 | - |
| May 29, 2026 | Teresa Briggs
Director
|
Grant | 729 | - |
| May 29, 2026 | Cain A. Hayes
Director
|
Grant | 729 | - |
| May 29, 2026 | Blake J Irving
Director
|
Grant | 729 | - |
| May 29, 2026 | Anna Marrs
Director
|
Grant | 729 | - |
| May 29, 2026 | Enrique T Salem
Director
|
Grant | 729 | - |
| May 29, 2026 | Peter Solvik
Director
|
Grant | 729 | - |
| May 29, 2026 | Mary Agnes Wilderotter
Director
|
Grant | 729 | - |
| Apr 2, 2026 | Robert Chatwani
Officer
|
Grant | 346 | $14.2K |
| Apr 2, 2026 | Blake Jeffrey Grayson
Chief Financial Officer
|
Grant | 255 | $10.5K |
| Apr 2, 2026 | Paula Hansen
Officer
|
Grant | 346 | $14.2K |
| Apr 2, 2026 | Mary Agnes Wilderotter
Director
|
Grant | 57.3K | - |
| Apr 1, 2026 | Allan C Thygesen
Chief Executive Officer
|
Sell | 26.3K | $1.3M |
| Apr 1, 2026 | James P Shaughnessy
Officer
|
Sell | 12.0K | $562.0K |
| Apr 1, 2026 | Paula Hansen
Officer
|
Sell | 6.0K | $281.0K |
| Apr 1, 2026 | Mary Agnes Wilderotter
Director
|
Sell | 3.0K | $144.5K |
| Apr 1, 2026 | Mary Agnes Wilderotter
Director
|
Option | 3.0K | $53.0K |
| Mar 18, 2026 | Robert Chatwani
Officer
|
Sell | 16.7K | $803.0K |
| Mar 13, 2026 | Robert Chatwani
Officer
|
Grant | 31.5K | - |
| Mar 13, 2026 | Blake Jeffrey Grayson
Chief Financial Officer
|
Grant | 37.4K | - |
| Mar 13, 2026 | Paula Hansen
Officer
|
Grant | 32.5K | - |
| Mar 13, 2026 | James P Shaughnessy
Officer
|
Grant | 21.0K | - |
| Mar 13, 2026 | Allan C Thygesen
Chief Executive Officer
|
Grant | 65.6K | - |
| Mar 5, 2026 | Anna Marrs
Director
|
Sell | 363 | $16.8K |
| Mar 4, 2026 | Anna Marrs
Director
|
Grant | 725 | - |
| Mar 3, 2026 | James Alexander Beer
Director
|
Sell | 450 | $20.3K |
| Mar 3, 2026 | Anna Marrs
Director
|
Sell | 365 | $16.4K |
| Mar 3, 2026 | Michael George Rosenbaum
Director
|
Grant | 522 | - |
| Feb 27, 2026 | Teresa Briggs
Director
|
Sell | 364 | $16.1K |
| Feb 27, 2026 | James Alexander Beer
Director
|
Grant | 729 | - |
| Feb 27, 2026 | Teresa Briggs
Director
|
Grant | 729 | - |
| Feb 27, 2026 | Cain A. Hayes
Director
|
Grant | 729 | - |
| Feb 27, 2026 | Blake J Irving
Director
|
Grant | 729 | - |
| Feb 27, 2026 | Anna Marrs
Director
|
Grant | 729 | - |
| Feb 27, 2026 | Enrique T Salem
Director
|
Grant | 729 | - |
| Feb 27, 2026 | Peter Solvik
Director
|
Grant | 729 | - |
| Feb 27, 2026 | Mary Agnes Wilderotter
Director
|
Grant | 729 | - |
| Jan 9, 2026 | Allan C Thygesen
Chief Executive Officer
|
Sell | 26.3K | $1.8M |
| Jan 9, 2026 | Blake Jeffrey Grayson
Chief Financial Officer
|
Sell | 6.5K | $455.0K |
| Jan 2, 2026 | James P Shaughnessy
Officer
|
Sell | 12.0K | $804.4K |
| Jan 2, 2026 | Paula Hansen
Officer
|
Sell | 6.0K | $402.3K |
| Dec 17, 2025 | Robert Chatwani
Officer
|
Sell | 15.5K | $1.1M |
| Dec 17, 2025 | Blake Jeffrey Grayson
Chief Financial Officer
|
Sell | 9.5K | $650.2K |
| Dec 15, 2025 | Robert Chatwani
Officer
|
Grant | 31.5K | - |
| Dec 15, 2025 | Blake Jeffrey Grayson
Chief Financial Officer
|
Grant | 37.5K | - |
| Dec 15, 2025 | Paula Hansen
Officer
|
Grant | 32.5K | - |
| Dec 15, 2025 | James P Shaughnessy
Officer
|
Grant | 21.0K | - |
| Dec 15, 2025 | Allan C Thygesen
Chief Executive Officer
|
Grant | 65.6K | - |
| Dec 11, 2025 | Robert Chatwani
Officer
|
Sell | 983 | $67.5K |
| Dec 10, 2025 | Peter Solvik
Director
|
Grant | 15.0K | - |
| Dec 5, 2025 | Anna Marrs
Director
|
Sell | 363 | $23.4K |
| Dec 4, 2025 | Anna Marrs
Director
|
Grant | 725 | - |
| Dec 3, 2025 | Michael George Rosenbaum
Director
|
Grant | 522 | - |
| Dec 2, 2025 | James Alexander Beer
Director
|
Sell | 450 | $30.8K |
| Dec 2, 2025 | Anna Marrs
Director
|
Sell | 365 | $25.0K |
| Nov 28, 2025 | Teresa Briggs
Director
|
Sell | 365 | $25.3K |
| Nov 28, 2025 | James Alexander Beer
Director
|
Grant | 729 | - |
| Nov 28, 2025 | Teresa Briggs
Director
|
Grant | 729 | - |
| Nov 28, 2025 | Cain A. Hayes
Director
|
Grant | 729 | - |
| Nov 28, 2025 | Blake J Irving
Director
|
Grant | 729 | - |
| Nov 28, 2025 | Anna Marrs
Director
|
Grant | 729 | - |
| Nov 28, 2025 | Enrique T Salem
Director
|
Grant | 729 | - |
| Nov 28, 2025 | Peter Solvik
Director
|
Grant | 729 | - |
| Nov 28, 2025 | Mary Agnes Wilderotter
Director
|
Grant | 729 | - |
| Oct 7, 2025 | Paula Hansen
Officer
|
Sell | 6.0K | $428.0K |
| Oct 3, 2025 | Paula Hansen
Officer
|
Grant | 245 | $14.5K |
| Oct 1, 2025 | Allan C Thygesen
Chief Executive Officer
|
Sell | 40.0K | $2.8M |
| Oct 1, 2025 | James P Shaughnessy
Officer
|
Sell | 7.5K | $534.0K |
| Oct 1, 2025 | Blake Jeffrey Grayson
Chief Financial Officer
|
Sell | 6.5K | $462.8K |
| Sep 17, 2025 | Robert Chatwani
Officer
|
Sell | 13.8K | $1.1M |
| Sep 17, 2025 | Blake Jeffrey Grayson
Chief Financial Officer
|
Sell | 9.5K | $790.2K |
| Sep 16, 2025 | James Alexander Beer
Director
|
Sell | 450 | $36.6K |
| Sep 15, 2025 | Peter Solvik
Director
|
Sell | 15.0K | $1.2M |
| Sep 15, 2025 | Robert Chatwani
Officer
|
Sell | 1.7K | $135.1K |
| Sep 15, 2025 | Anna Marrs
Director
|
Sell | 728 | $58.5K |
| Sep 15, 2025 | Robert Chatwani
Officer
|
Grant | 31.5K | - |
| Sep 15, 2025 | Blake Jeffrey Grayson
Chief Financial Officer
|
Grant | 37.4K | - |
| Sep 15, 2025 | Paula Hansen
Officer
|
Grant | 80.5K | - |
| Sep 15, 2025 | James P Shaughnessy
Officer
|
Grant | 21.0K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.